Thomas M. Ray Net Worth

The estimated Net Worth of Thomas M. Ray is at least $98.7 Million dollars as of 16 August 2016. Thomas Ray owns over 21,179 units of Cencora stock worth over $92,405,957 and over the last 14 years Thomas sold COR stock worth over $6,264,603.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Thomas Ray COR stock SEC Form 4 insiders trading

Thomas has made over 17 trades of the Cencora stock since 2011, according to the Form 4 filled with the SEC. Most recently Thomas sold 21,179 units of COR stock worth $1,727,571 on 16 August 2016.

The largest trade Thomas's ever made was exercising 165,639 units of Cencora stock on 8 August 2014 worth over $2,587,281. On average, Thomas trades about 16,631 units every 73 days since 2010. As of 16 August 2016 Thomas still owns at least 391,186 units of Cencora stock.

You can see the complete history of Thomas Ray stock trades at the bottom of the page.

What's Thomas Ray's mailing address?

Thomas's mailing address filed with the SEC is 1050 17TH STREET, SUITE 800, , DENVER, CO, 80265.

Insiders trading at Cencora

Over the last 14 years, insiders at Cencora have traded over $67,682,023 worth of Cencora stock and bought 34,206 units worth $1,080,918 . The most active insiders traders include Realty Iii, Gp, L.L.C.Carly..., Iv Aiv Gp, L.L.C.Crp Iv Aiv... und Group Management L.L.C.Carl.... On average, Cencora executives and independent directors trade stock every 13 days with the average trade being worth of $18,365,869. The most recent stock trade was executed by Brian Warren on 5 November 2021, trading 850 units of COR stock currently worth $130,577.

What does Cencora do?

amerisourcebergen is driving innovative partnerships with global manufacturers, providers and pharmacies to improve product access and efficiency throughout the healthcare supply chain and enhance patient care. as the leader in global sourcing and distribution, we source and distribute brand, generic, specialty, otc pharmaceuticals and other healthcare products. we increase the effectiveness and efficiency of your supply chain by ensuring products are delivered securely, consistently and cost-effectively, improving product access for pharmacies, providers and patients. our pharmacy solutions result in greater operational efficiency, cost control, growth opportunities and patient safety. our provider solutions drive operational efficiency, financial performance and improve quality of care. our manufacturer solutions maximize success at every stage of the product lifecycle. amerisourcebergen. where knowledge, reach and partnership shape healthcare delivery.

Complete history of Thomas Ray stock trades at Cencora

Cencora executives and stock owners

Cencora executives and other stock owners filed with the SEC include:

• Paul Szurek,
  President, Chief Executive Officer, Director
• Steven Smith,
  Chief Revenue Officer
• Jeffrey Finnin,
  Chief Financial Officer
• Derek McCandless,
  Senior Vice President - Legal, General Counsel, Secretary
• Brian Warren,
  Senior Vice President - Development and Product Engineering
• David Wilson,
  Lead Independent Director
• John Thompson,
  Independent Director
• Michael Koehler,
  Independent Director
• Jean Bua,
  Independent Director
• Kelly Chambliss,
  Independent Director
• Patricia Higgins,
  Independent Director
• James Attwood,
  Independent Director
• Juan Font,
  Senior Vice President - General Management
• Maile Kaiser,
  Senior Vice President of Sales
• Robert Stuckey,
  Independent Chairman of the Board
• Thomas M. Ray,
  President and CEO
• Dominic M. Tobin,
  SVP, Operations
• Realty Iii, Gp, L.L.C.Carly...,
  
• Iv Aiv Gp, L.L.C.Crp Iv Aiv...,
  
• Group Management L.L.C.Carl...,
  
• Anthony Hatzenbuehler,
  SVP, Field Operations
• Mark R Jones,
  Chief Accounting Officer
• Group Management L.L.C.Carl...,
  
• Robert K. Rockwood,
  SVP, Acquisitions
• Jarrett Appleby,
  Chief Operating Officer
• Christopher K Ancell,
  SVP, Sales
• Billie R. Haggard,
  SVP, Data Centers
• Christopher M. Bair,
  SVP, Sales
• David W. Dunn,
  SVP, Strategy and Marketing
• Chuck D. Price,
  SVP, Information Technology
• Robert M. Sistek,
  SVP, Capital Markets
• Deedee M. Beckman,
  Chief Financial Officer
• Realty V Gp, L.L.C.Carlyle ...,
  
• Iv Aiv Gp, L.L.C.Crp Iv Aiv...,
  
• Michael Millegan,
  Director
• Aleksandra Krusko,
  SVP, IT and Digitization